December 13, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today that a landmark meta-analysis confirming the efficacy of continuous wound catheters delivering local anesthetic, including ON-Q, for post surgical analgesia (pain relief) was published in the December 2006 Journal of the American College of Surgeons (JACS).

November 22, 2006
I-FLOW CORPORATION (NASDAQ:IFLO) announced today that it will address institutional shareholders at the Lazard Capital Markets Annual Life Sciences Conference, Tuesday morning, November 28, 2006 at 8:30 a.m. EST.

October 26, 2006
I-FLOW CORPORATION (NASDAQ:IFLO) today announced financial results for the third quarter ended September 30, 2006, highlighted by a 34% increase in Regional Anesthesia revenue and a 31% increase in total third quarter revenue from continuing operations compared to the same period of 2005.

October 24, 2006
I-Flow Corporation (NASDAQ:IFLO) plans to release financial results for the third quarter ended September 30, 2006 at approximately 7:30 a.m. EDT on Thursday, October 26, 2006. I-Flow Corporation has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter.

October 9, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today that it has been named to the Orange County Technology Fast 50 for a record tenth time. The Orange County Technology Fast 50 program, sponsored by Deloitte & Touche LLP, seeks to find, acknowledge and reward those high-growth technology companies with the drive to succeed. The rankings are based on the percentage of revenue growth over the past five years.

October 2, 2006
I-FLOW CORPORATION (NASDAQ:IFLO) announced today that it has signed a definitive agreement to sell its InfuSystem, Inc. subsidiary to HAPC, Inc. (OTCBB:HAPN) (formerly Healthcare Acquisition Partners Corp.) for $140 million in the form of cash and a secured note, subject to certain purchase price adjustments based on the level of working capital.

September 26, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today the beginning of a human study in colorectal surgery to evaluate the antimicrobial benefits of the ON-Q(R) PainBuster System, its market-leading post-surgical pain relief brand. The study, which will include utilization of the ON-Q SilverSoaker(R) Antimicrobial Catheter,

September 21, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at the UBS Global Life Sciences Conference on Tuesday afternoon, September 26, 2006 at 2:00 p.m. EDT. The Conference is scheduled for September 25 - 28, at the Grand Hyatt Hotel, New York City.

September 7, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today an agreement with Amerinet(R) to make the ON-Q(R) line of post-surgical pain relief devices available to its member facilities. The contract includes the ON-Q PainBuster(R) Post-Operative Pain Relief System, the ON-Q C-bloc Continuous Nerve Block System and the ON-Q SilverSoaker(R) Catheter.

July 27, 2006
I-Flow Corporation (NASDAQ:IFLO):I-Flow Corporation (NASDAQ:IFLO) today announced net income for the second quarter ended June 30, 2006 of $433,000, or $0.02 per basic and diluted share, which included stock-based compensation expense of $1,733,000. This compares to a net loss of $645,000, or $0.03 per basic and diluted share, for the second quarter of 2005, which included stock-based compensation expense of $948,000.

July 26, 2006
I-Flow Corp. (NASDAQ:IFLO) announced today an agreement with a leading group purchasing organization (GPO), Broadlane, to make the ON-Q(R) PainBuster(R) Post-Op Pain Relief System available to their customers.

July 25, 2006
I-Flow Corp. (NASDAQ:IFLO) announced today that it signed contracts with Three Rivers Provider Network and USA Managed Care Organization and also with a nationally renowned East Coast health plan, which is affiliated with a medical school and a hospital system, to reimburse the cost of ON-Q(R) for outpatient surgeries in ambulatory surgery centers (ASCs).

July 19, 2006
I-Flow Corporation (NASDAQ:IFLO) plans to release financial results for the second quarter ended June 30, 2006 at approximately 7:30 a.m. EDT on Thursday, July 27, 2006. I-Flow Corporation has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter.

June 26, 2006
I-FLOW CORPORATION (Nasdaq:IFLO) announced today that it will address institutional shareholders at the inaugural Jefferies Life Sciences Conference on Tuesday, June 27, 2006 at 8:30 a.m. EDT. The Conference is scheduled for June 27 through June 28 at the Mandarin Oriental Hotel in New York City.

May 10, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders and other investors at the 2006 Bank of America Securities Health Care Conference on Tuesday afternoon, May 16, 2006 at 4:40 p.m. PDT. The Conference is scheduled for May 16th through May 18th at the Four Seasons Hotel, Las Vegas, Nevada.

April 27, 2006
I-FLOW CORPORATION (Nasdaq:IFLO) today announced unaudited financial results for its first quarter ended March 31, 2006, highlighted by a 32% increase in Regional Anesthesia sales, a 21% increase in total revenue to new records, and a 76% decrease in net loss compared to the first quarter of 2005.

March 21, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today that a key ON-Q colorectal study conducted at the Cleveland Clinic Florida was published in the Journal of the American College of Surgeons (JACS). This latest publication complements the more than 50 published and presented ON-Q studies to date.

March 17, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today that after undergoing gastric bypass surgery on Saturday, March 11, Anthony Davis, a former two-time All-American USC Trojan football hero, got off the sidelines quicker when ON-Q PainBuster was used. Because Davis' surgeon, Dr. Alan Wittgrove, chose to use ON-Q to automatically deliver a non-narcotic local anesthetic to the surgical site to treat his patient's pain,

March 2, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at the SG Cowen & Co. 26th Annual Health Care Conference, Thursday morning, March 9, 2006 at 8:00 a.m. EST.

February 21, 2006
I-FLOW CORPORATION (NASDAQ:IFLO) today announced unaudited financial results for its fourth quarter and year ended December 31, 2005. Revenue for 2005 increased 41% to a record $100,644,000, exceeding the $100 million milestone for the first time, driven by a 54% increase in Regional Anesthesia sales to a record $49,850,000 and a 47% increase in Oncology Infusion Services revenue to a record $28,525,000.

February 14, 2006
I-Flow Corporation (NASDAQ:IFLO) announced today that it will address institutional shareholders at The 18th Annual Roth Capital Partners Growth Stock Conference on Tuesday, February 21, 2006 at 1:00 p.m. PST.